drugset
Drugs / controlled nitric oxide releasing patch
last change Mar 2009 re-read 9 days ago

controlled nitric oxide releasing patch

also known as NOP

Other / unclassified

Developed for
cutaneous leishmaniasis
Investigated by
Fundación Cardiovascular de Colombia · Secretaria de Salud de Santander · Secretaria de Salud de Tolima · The University of Akron · Universidad de Antioquia · Universidad de Santander

Trials 1

today NCT00317629 · Ph 3
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00317629 May 2006 → Jan 2009 cutaneous leishmaniasis Fundación Cardiovascular de Colombia Terminated No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as controlled nitric oxide releasing patch ClinicalTrials.gov intervention name — accepted as the source's own label NCT00317629 ↗
Known as NOP “Upon hydration, this Nitric Oxide Releasing Patch (NOP) produces a stable release of 3.5 µmol of NO during 12 hrs” NCT00317629 ↗
Modality Other / unclassified “a multilayer transdermal patch has been produced” NCT00317629 ↗